Anti-AKR1C3 antibody
| Name | Anti-AKR1C3 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab27491 |
| Prices | $382.00 |
| Sizes | 100 µg |
| Host | Goat |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA WB |
| Species Reactivities | Human |
| Antigen | Synthetic peptide: CFASHPNYPYSDEY , corresponding to C terminal amino acids 311-323 of Human AKR1C3 |
| Description | Goat Polyclonal |
| Gene | AKR1C3 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Anti-AKR1C3 antibody (ab27491) at 0.03 µg/ml + Human breast lysate (35µg protein in RIPA buffer). developed using the ECL technique
Product References
Genes for prostaglandin synthesis, transport and inactivation are differentially - Genes for prostaglandin synthesis, transport and inactivation are differentially
Phillips RJ, Al-Zamil H, Hunt LP, Fortier MA, Lopez Bernal A. Mol Hum Reprod. 2011 Jan;17(1):1-13.
The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F - The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F
Bresson E, Boucher-Kovalik S, Chapdelaine P, Madore E, Harvey N, Laberge PY, Leboeuf M, Fortier MA. J Clin Endocrinol Metab. 2011 Jan;96(1):210-9.
Reduction of doxorubicin and oracin and induction of carbonyl reductase in human - Reduction of doxorubicin and oracin and induction of carbonyl reductase in human
Gavelova M, Hladikova J, Vildova L, Novotna R, Vondracek J, Krcmar P, Machala M, Skalova L. Chem Biol Interact. 2008 Oct 22;176(1):9-18.